Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Removal of UroLume endoprosthesis: Experience of the North American study group for detrusor-sphincter dyssynergia application
Autore:
Gajewski, JB; Chancellor, MB; Ackman, CFD; Appell, RA; Bennett, J; Binard, J; Boone, TB; Chetner, MP; Crewalk, JA; Defalco, A; Foote, J; Green, B; Juma, S; Jung, SY; Linsenmeyer, TA; Macaluso, JN; Macmillan, R; Mayo, M; Ozawa, H; Roehrborn, CG; Schmidt, J; Shenot, PJ; Stone, A; Vazquez, A; Killorin, W; Rivas, DA;
Indirizzi:
Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA Univ Pittsburgh Pittsburgh PA USA 15260 Sch Med, Pittsburgh, PA 15260 USA Thomas Jefferson Univ, Philadelphia, PA 19107 USA Thomas Jefferson Univ Philadelphia PA USA 19107 hiladelphia, PA 19107 USA Louisiana State Univ, Med Ctr, New Orleans, LA USA Louisiana State Univ New Orleans LA USA iv, Med Ctr, New Orleans, LA USA Shepherd Spinal Ctr, Atlanta, GA USA Shepherd Spinal Ctr Atlanta GA USAShepherd Spinal Ctr, Atlanta, GA USA Univ Calif San Diego, Vet Affairs Med Ctr, San Diego, CA 92161 USA Univ Calif San Diego San Diego CA USA 92161 Ctr, San Diego, CA 92161 USA Univ Calif Davis, Davis, CA 95616 USA Univ Calif Davis Davis CA USA 95616Univ Calif Davis, Davis, CA 95616 USA Vet Affairs Med Ctr, Dallas, TX USA Vet Affairs Med Ctr Dallas TX USAVet Affairs Med Ctr, Dallas, TX USA Baylor Coll Med, Houston, TX 77030 USA Baylor Coll Med Houston TX USA 77030 ylor Coll Med, Houston, TX 77030 USA Univ Washington, Seattle, WA 98195 USA Univ Washington Seattle WA USA 98195 iv Washington, Seattle, WA 98195 USA Univ Med & Dent New Jersey, Kessler Inst Rehabil, W Orange, NJ USA Univ Med & Dent New Jersey W Orange NJ USA nst Rehabil, W Orange, NJ USA Univ Puerto Rico, San Juan, PR 00936 USA Univ Puerto Rico San Juan PR USA00936 uerto Rico, San Juan, PR 00936 USA Univ S Florida, Vet Affairs Med Ctr, Tampa, FL USA Univ S Florida Tampa FL USA Florida, Vet Affairs Med Ctr, Tampa, FL USA Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada Montreal Gen Hosp Montreal PQ Canada H3G 1A4 Montreal, PQ H3G 1A4, Canada Misericordia Hosp, Edmonton, AB, Canada Misericordia Hosp Edmonton AB Canada ricordia Hosp, Edmonton, AB, Canada Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada Queen Elizabeth II Hlth Sci Ctr Halifax NS Canada r, Halifax, NS, Canada E Toronto Gen Hosp, Toronto, ON, Canada E Toronto Gen Hosp Toronto ON Canada ronto Gen Hosp, Toronto, ON, Canada
Titolo Testata:
JOURNAL OF UROLOGY
fascicolo: 3, volume: 163, anno: 2000,
pagine: 773 - 776
SICI:
0022-5347(200003)163:3<773:ROUEEO>2.0.ZU;2-V
Fonte:
ISI
Lingua:
ENG
Soggetto:
URETHRAL STRICTURES; URINARY SPHINCTER; STENTS; PROSTHESIS; WALLSTENT; INJURIES;
Keywords:
urethra; prosthesis; urination; stent; bladder, neurogenic;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
16
Recensione:
Indirizzi per estratti:
Indirizzo: Gajewski, JB New Halifax Infirm, Dept Urol, 1796 Summer St,Level 100,Room 1225B, Halifax, NS B3H 3A7, Canada New Halifax Infirm 1796 Summer St,Level 100,Room 1225B Halifax NS Canada B3H 3A7
Citazione:
J.B. Gajewski et al., "Removal of UroLume endoprosthesis: Experience of the North American study group for detrusor-sphincter dyssynergia application", J UROL, 163(3), 2000, pp. 773-776

Abstract

Purpose: We present the experience of the North American UroLume Multicenter Study Group with removal of the UroLume(+)(+) endoprosthesis. Materials and Methods: A total of 160 neurologically impaired patients were enrolled in the North American UroLume Multicenter Study Group for detrusor external sphincter dyssynergia application. Analysis was performed in 2 groups of patients in which the device was removed during insertion and after implantation, respectively. Results: Device retrieval was required during insertion in 21 patients (13%) mainly due to misplacement or migration in 17. Extraction was done with minimal complications and in all but 2 cases subsequent UroLume implantation was successful. Of 158 men with the device in place 31 (19.6%) required removal. In 34 procedures 44 devices were removed, mainly due to migration. Time from implantation to removal ranged from 4 days to 66 months (mean 22 months). The UroLume was removed en bloc in 20 cases and in parts or wire by wire in 19. The majority of patients had no or minimal complications after extraction. Only 2 patients had serious temporary complications, including bleeding and urethral injury, with no lasting consequences. No malignancydeveloped as a result of UroLume insertion. Conclusions: While there is a potential for urethral injury and bleeding, UroLume endoprosthesis removal is largely a simple procedure with minimal complications and consequences.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 21:21:09